New Site of Modification of 23S rRNA Associated with Clarithromycin Resistance of Helicobacter pylori Clinical Isolates

Resistance of Helicobacter pylori to clarithromycin occurs with a prevalence ranging from 0 to 15%. This has an important clinical impact on dual and triple therapies, in which clarithromycin seems to be the better choice to achieve H. pylori eradication. In order to evaluate the possibility of new...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Fontana, Carla, Favaro, Marco, Minelli, Silvia, Criscuolo, Anna Angela, Pietroiusti, Antonio, Galante, Alberto, Favalli, Cartesio
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2002
Matèries:
Mechanisms of Resistance
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC132752/
https://ncbi.nlm.nih.gov/pubmed/12435674
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.46.12.3765-3769.2002
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars